OARK | XYLE | OARK / XYLE | |
Gain YTD | 3.051 | 1.500 | 203% |
Net Assets | 70M | 2.04M | 3,426% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 60.00 | 13.87 | 433% |
Yield | 38.40 | 6.71 | 572% |
Fund Existence | 2 years | 2 years | - |
OARK | XYLE | |
---|---|---|
RSI ODDS (%) | N/A | 11 days ago27% |
Stochastic ODDS (%) | 11 days ago79% | 11 days ago45% |
Momentum ODDS (%) | 11 days ago87% | 11 days ago81% |
MACD ODDS (%) | N/A | 11 days ago75% |
TrendWeek ODDS (%) | 11 days ago87% | 11 days ago86% |
TrendMonth ODDS (%) | 11 days ago81% | 11 days ago87% |
Advances ODDS (%) | 13 days ago90% | about 1 month ago86% |
Declines ODDS (%) | 11 days ago78% | 17 days ago43% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 11 days ago85% | 11 days ago86% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEEIX | 14.84 | 0.08 | +0.54% |
JHancock Infrastructure I | |||
VYMSX | 20.12 | 0.08 | +0.40% |
Voya Mid Cap Research Enhanced Index I | |||
FNDMX | 11.40 | 0.04 | +0.35% |
Fidelity Series Sust Non-US Dev Mrkt Fd | |||
JEPIX | 14.54 | 0.04 | +0.28% |
JPMorgan Equity Premium Income I | |||
FBTAX | 26.09 | -0.13 | -0.50% |
Fidelity Advisor Biotechnology A |
A.I.dvisor indicates that over the last year, XYLE has been loosely correlated with AMP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XYLE jumps, then AMP could also see price increases.
Ticker / NAME | Correlation To XYLE | 1D Price Change % | ||
---|---|---|---|---|
XYLE | 100% | N/A | ||
AMP - XYLE | 61% Loosely correlated | +1.05% | ||
ROP - XYLE | 59% Loosely correlated | +0.62% | ||
MA - XYLE | 58% Loosely correlated | +0.30% | ||
IR - XYLE | 57% Loosely correlated | +1.25% | ||
TEL - XYLE | 56% Loosely correlated | +1.41% | ||
More |